Chemical and Pharmaceutical Bulletin p. 777 - 782 (1995)
Update date:2022-08-05
Topics:
Saito
Harada
Nishida
Inouye
Kubo
Treatment of (-)-saframycin A (1a) with selenium oxide in acetic acid afforded (-)-saframycin G (1g), and a catalytic reduction and regioselective oxidation sequence afforded the saframycin Mx type compound (3). We applied this methodology to the transformation of (±)-5-hydroxysaframycin B (11) to the hydroquinone (1e). Acetylation of 1e with acetic anhydride in pyridine gave the triacetate (13), which is identical with the triacetyl derivative of natural saframycin E.
View MoreContact:+91 - 22 - 26355700
Address:17, Lotus Business Park, Andheri West
Tianjin Tongde Biological Technology Co., Ltd.
Contact:86-22-23309138
Address:Room 402, bulidingE3 Detection certification park, XiQingDistrict, Tianjin City
Tianjin Jiuri New Materials Co., Ltd.
Contact:+86-22-58889220
Address:C-5/6, Vison Hill, No.1 Gonghua Road, Huayuan Hi-tech Park, Tianjin, China.
Contact:(86) 731 88718666
Address:Room 1222, Unit 4, Building B, Shangcheng, No.47, Kaiyuan East Road.
Feis International Trade Co,. Ltd
Contact:13961823444-18235944442
Address:Wuxi jiangsu
Doi:10.1016/j.tetasy.2014.04.001
(2014)Doi:10.1021/ol501301w
(2014)Doi:10.1021/acs.jmedchem.7b00592
(2017)Doi:10.1039/c4gc00273c
(2014)Doi:10.1016/j.bmc.2018.05.045
(2018)Doi:10.1016/j.bioorg.2021.104965
(2021)
